Africa bears a disproportionate infectious disease burden, with HIV, tuberculosis, and malaria posing ongoing threats ...

Vaccination campaigns have nearly eradicated some of the most deadly and transmissible diseases. In a rising tide of vaccine ...

The European Commission has approved Johnson & Johnson's Ebola vaccine, developed by its Janssen pharmaceuticals unit and Bavarian Nordic. This is the first major regulatory approval of the ...

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Receives USPTO Notice of Allowance for Marburg Hemorrhagic Fever Vaccine Patent 09.04.2025 / 15:07 CET/CEST The issuer is solely responsible ...

Sweeping job cuts and reorganizations taking place at the US Department of Health and Human Services under Secretary Robert F ...

Nowadays, there are effective approved vaccines and treatments for some species of Ebola. But the vaccine supply is limited and the current antibody-based treatments have to be stored in cold ...

A report from the Johns Hopkins Bloomberg School of Public Health recently found that costs averted by vaccine programmes in 73 countries will add up to nearly $782 billion over the next decade. Craig ...

A global emergency stockpile of Ebola vaccine is being deployed to curb the epidemic, although experts are confident that synergies in public health practises will ensure a rapid response to both.

Declining vaccination rates are leaving communities vulnerable to the spread of debilitating, preventable diseases like ...

President Donald Trump's administration plans to end U.S. funding for Gavi, an organization that helps buy vaccines for ...

G avi, the Vaccine Alliance, supplies vaccines to nearly half of the world’s children. For decades, governments, institutions ...